Definitive Healthcare Corp. (NASDAQ:DH) Receives $4.28 Consensus Target Price from Analysts

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have earned a consensus rating of “Reduce” from the seven ratings firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $4.28.

Several equities analysts recently weighed in on DH shares. Robert W. Baird set a $4.00 price target on shares of Definitive Healthcare in a research report on Friday, August 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, October 8th. Finally, Stifel Nicolaus increased their target price on shares of Definitive Healthcare from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Friday, August 8th.

Hedge Funds Weigh In On Definitive Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DH. Raymond James Financial Inc. bought a new position in Definitive Healthcare during the second quarter worth about $32,000. Farther Finance Advisors LLC bought a new position in Definitive Healthcare during the second quarter worth about $33,000. Savant Capital LLC bought a new position in shares of Definitive Healthcare in the second quarter valued at approximately $45,000. Los Angeles Capital Management LLC bought a new position in shares of Definitive Healthcare in the second quarter valued at approximately $51,000. Finally, Hsbc Holdings PLC bought a new position in shares of Definitive Healthcare in the first quarter valued at approximately $52,000. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Price Performance

DH opened at $2.77 on Friday. The firm has a market cap of $396.50 million, a P/E ratio of -1.05 and a beta of 1.65. The firm has a 50-day moving average of $3.58 and a 200 day moving average of $3.56. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. Definitive Healthcare has a fifty-two week low of $2.15 and a fifty-two week high of $5.68.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.